Alteplase Trial Puts ENCHANTED Asian Sites On The Map
This article was originally published in PharmAsia News
Executive Summary
As well as establishing the benefits of lower dosing, new results from a multinational clinical trial with clot-buster alteplase have highlighted the strong performance of Asian study sites, breaking some perceptions in the process.